Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – The results of a small trial suggest that vitamin B12 is a safe, effective, and inexpensive treatment for recurrent aphthous stomatitis (RAS). “The…
Dr. David Best interviews Fabio Bibancos, DDS, PhD, the founder of “Dentists for Good” at the Greater New York Dental Meeting. This charity organization was started in Sao…
NEW YORK (Reuters Health) – After pregnancy, women with multiple sclerosis may substantially reduce their risk of relapses if they breastfeed their infants, without adding supplemental formula feedings,…
NEW YORK (Reuters Health) – The risk of visual field loss with the antiepileptic drug vigabatrin is lower when it is given during infancy rather than later in…
NEW YORK (Reuters Health) – Fewer than 1% of adolescents in the US are potential candidates for cholesterol-lowering agents, based on updated guidelines released last year by the…
NEW YORK (Reuters Health) – In patients with rheumatoid arthritis, anti-tumor necrosis factor (TNF) treatment with adalimumab and infliximab is associated with a small increased risk of herpes…
NEW YORK (Reuters Health) – In a study of healthy adolescents, a quadrivalent meningococcal glycoconjugate vaccine was more immunogenic than the currently licensed unconjugated vaccine. Adolescents are at…
NEW YORK (Reuters Health) – A gene therapy protocol developed by scientists in Australia and the US for treatment of HIV-1 infection suppressed viral load and increased CD4…
NEW YORK (Reuters Health) – An injection of autologous cultured osteoblasts can accelerate the healing of long-bone fractures, according to a report in the February 12th online issue…
NEW YORK (Reuters Health) – New research suggests that B-cell clones may be a useful early marker for chronic lymphocytic leukemia (CLL) since they are found in nearly…
